7459 — Medipal Holdings Share Price
Last trade - 00:00- ¥661bn
- ¥536bn
- ¥4tn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 14.3 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -10.71% | ||
| Dividend Yield (f) | 2.56% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.07 | ||
| Price to Tang. Book | 1.14 | ||
| Price to Free Cashflow | 17.53 | ||
| Price to Sales | 0.17 | ||
| EV to EBITDA | 7.7 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.11% | ||
| Return on Equity | 7.01% | ||
| Operating Margin | 1.06% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 3,290,921 | 3,360,008 | 3,558,732 | 3,671,328 | 3,817,354 | 3,949,303 | 4,054,340 | 3.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -2.16 | +38.92 | -4.87 | +2.54 | +37.67 | -13.88 | -8.5 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medipal Holdings Corp is a Japan-based company principally engaged in the wholesale of pharmaceuticals, cosmetics, daily necessities, and veterinary medicines. The Company operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The Company also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.
Directors
- Shuichi Watanabe CHM (74)
- Yasuhiro Chofuku VPR (71)
- Toshihide Yoda SMD (63)
- Yuji Sakon MDR (73)
- Kuniaki Imagawa PRE (65)
- Mitsuko Kagami IND (68)
- Toshio Asano IND (73)
- Kuniko Shoji IND (72)
- Hiroshi Iwamoto IND (67)
- Atsushi Takumiya SEO
- Hidemitsu Wakita CEX (63)
- Masahiro Fujimaki EXO
- Tetsuya Shoji SEO
- Kotaro Yamamoto SEO
- Last Annual
- March 31st, 2026
- Last Interim
- September 30th, 2026
- Incorporated
- May 6th, 1923
- Public Since
- September 14th, 1995
- No. of Shareholders
- 9,606
- No. of Employees
- 13,024
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 204,698,231
- Address
- 3-1-1, Kyobashi, CHUO-KU, 104-8461
- Web
- https://www.medipal.co.jp
- Phone
- +81 335175800
- Auditors
- KPMG AZSA LLC
Latest News for 7459
Upcoming Events for 7459
Q3 2027 Medipal Holdings Corp Earnings Release
Dividend For 7459.T - 44.0000 JPY
Similar to 7459
ASKA Pharmaceutical Holdings
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings
Tokyo Stock Exchange
CanBas
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
As of Today at 12:01 UTC, shares in Medipal Holdings are trading at ¥3,228. This share price information is delayed by 15 minutes.
Shares in Medipal Holdings last closed at ¥3,228 and the price had moved by +22.3% over the past 365 days. In terms of relative price strength the Medipal Holdings share price has outperformed the Nikkei 225 Index by +2.57% over the past year.
The overall consensus recommendation for Medipal Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Medipal Holdings dividend yield is 2.42% based on the trailing twelve month period.
Last year, Medipal Holdings paid a total dividend of ¥78, and it currently has a trailing dividend yield of 2.42%.Looking ahead, shares in Medipal Holdings are due to go ex-dividend on 2027-03-30 and the next dividend pay date is 2026-12-02.
Medipal Holdings are due to go ex-dividend on 2027-03-30 and the next dividend pay date is 2026-12-02. The historic dividend yield on Medipal Holdings shares is currently 2.42%.
To buy shares in Medipal Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥3,228, shares in Medipal Holdings had a market capitalisation of ¥661bn.
Here are the trading details for Medipal Holdings:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 7459
Based on an overall assessment of its quality, value and momentum Medipal Holdings is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Medipal Holdings is ¥3,030. That is 6.13% below the last closing price of ¥3,228.
Analysts covering Medipal Holdings currently have a consensus Earnings Per Share (EPS) forecast of ¥238 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medipal Holdings. Over the past six months, its share price has outperformed the Nikkei 225 Index by +14.28%.
As of the last closing price of ¥3,228, shares in Medipal Holdings were trading +11.83% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medipal Holdings PE ratio based on its reported earnings over the past 12 months is 14.3. The shares last closed at ¥3,228.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medipal Holdings' management team is headed by:
- Shuichi Watanabe - CHM
- Yasuhiro Chofuku - VPR
- Toshihide Yoda - SMD
- Yuji Sakon - MDR
- Kuniaki Imagawa - PRE
- Mitsuko Kagami - IND
- Toshio Asano - IND
- Kuniko Shoji - IND
- Hiroshi Iwamoto - IND
- Atsushi Takumiya - SEO
- Hidemitsu Wakita - CEX
- Masahiro Fujimaki - EXO
- Tetsuya Shoji - SEO
- Kotaro Yamamoto - SEO